W H Gerlich

Summary

Affiliation: Justus-Liebig-University Giessen
Country: Germany

Publications

  1. ncbi request reprint [Hepatitis B and C. Risk of transmission from infected health care workers to patients]
    W H Gerlich
    Justus Liebig Universitat, Giessen
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 47:369-78. 2004
  2. ncbi request reprint Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients
    R N Gunson
    West of Scotland Specialist Virology Centre, Gartnavel General Hospital, 1053 Great Western Road, G12 OZA Glasgow, UK
    J Clin Virol 27:213-30. 2003
  3. pmc Outbreak of hepatitis B in a nursing home associated with capillary blood sampling
    J M Dreesman
    Governmental Institute of Public Health of Lower Saxony, D 30449 Hannover, Germany
    Epidemiol Infect 134:1102-13. 2006
  4. ncbi request reprint Combination therapy of active HBsAg vaccination and interferon-alpha in interferon-alpha nonresponders with chronic hepatitis B
    T Heintges
    Department of Gastroenterology, Hepatology and Infectious Diseases, , Germany
    Dig Dis Sci 46:901-6. 2001
  5. ncbi request reprint Optimised conditions for the production of hepatitis B virus from cell culture
    D Glebe
    , , Giessen, Germany
    Intervirology 44:370-8. 2001
  6. ncbi request reprint Molecular approaches to validate disinfectants against human hepatitis B virus
    C A Jursch
    Eurovir Hygiene Institute, Luckenwalde, Germany
    Med Microbiol Immunol 190:189-97. 2002
  7. ncbi request reprint Diagnostic problems caused by HBsAg mutants-a consensus report of an expert meeting
    W H Gerlich
    Institute of Medical Virology, Justus Leibig University, Frankfurterstrasse 107, DE 35392 Giessen, Germany
    Intervirology 47:310-3. 2004
  8. ncbi request reprint Methods for validation of hepatitis B virus inactivation
    W H Gerlich
    Institute for Medical Virology, National Consulting Laboratory for hepatitis B, C and Blood Transmissible Virus Diseases, Justus Liebig University, Giessen, Germany
    Dev Biol (Basel) 118:113-22. 2004
  9. ncbi request reprint Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus
    W H Gerlich
    Institute of Medical Virology, Justus Liebig University, Giessen, Germany
    J Viral Hepat 14:16-21. 2007

Collaborators

Detail Information

Publications9

  1. ncbi request reprint [Hepatitis B and C. Risk of transmission from infected health care workers to patients]
    W H Gerlich
    Justus Liebig Universitat, Giessen
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 47:369-78. 2004
    ..Infected staff with viremia must either abstain from exposure-prone procedures or have a decision from an expert committee on the acceptability of such procedures in view of the individual infection status...
  2. ncbi request reprint Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients
    R N Gunson
    West of Scotland Specialist Virology Centre, Gartnavel General Hospital, 1053 Great Western Road, G12 OZA Glasgow, UK
    J Clin Virol 27:213-30. 2003
    ..The document is designed to complement existing guidelines or form the basis for the development of new guidelines. This guidance is applicable to all HCWs who perform EPP, whether newly appointed or already in post...
  3. pmc Outbreak of hepatitis B in a nursing home associated with capillary blood sampling
    J M Dreesman
    Governmental Institute of Public Health of Lower Saxony, D 30449 Hannover, Germany
    Epidemiol Infect 134:1102-13. 2006
    ..6, P < 0.001, adjusted OR 8.5, P = 0.017). Control measures were implemented. Serological controls after 6 and 18 months revealed that the outbreak was brought under control...
  4. ncbi request reprint Combination therapy of active HBsAg vaccination and interferon-alpha in interferon-alpha nonresponders with chronic hepatitis B
    T Heintges
    Department of Gastroenterology, Hepatology and Infectious Diseases, , Germany
    Dig Dis Sci 46:901-6. 2001
    ..This combination therapy seems to offer a new and promising approach for patients with chronic hepatitis B virus infection...
  5. ncbi request reprint Optimised conditions for the production of hepatitis B virus from cell culture
    D Glebe
    , , Giessen, Germany
    Intervirology 44:370-8. 2001
    ..However, combinations of these parameters optimised cell culture conditions and reproducibly increased the release of HBV particles about 100-fold to titres >10(8) GE/ml of culture medium...
  6. ncbi request reprint Molecular approaches to validate disinfectants against human hepatitis B virus
    C A Jursch
    Eurovir Hygiene Institute, Luckenwalde, Germany
    Med Microbiol Immunol 190:189-97. 2002
    ..The molecular alteration and disintegration epitope and genome test may therefore be suitable to measure antiviral activity of disinfectants against HBV...
  7. ncbi request reprint Diagnostic problems caused by HBsAg mutants-a consensus report of an expert meeting
    W H Gerlich
    Institute of Medical Virology, Justus Leibig University, Frankfurterstrasse 107, DE 35392 Giessen, Germany
    Intervirology 47:310-3. 2004
  8. ncbi request reprint Methods for validation of hepatitis B virus inactivation
    W H Gerlich
    Institute for Medical Virology, National Consulting Laboratory for hepatitis B, C and Blood Transmissible Virus Diseases, Justus Liebig University, Giessen, Germany
    Dev Biol (Basel) 118:113-22. 2004
  9. ncbi request reprint Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus
    W H Gerlich
    Institute of Medical Virology, Justus Liebig University, Giessen, Germany
    J Viral Hepat 14:16-21. 2007
    ..All tests should be as sensitive as feasible, but even then occult infection may be missed. Reliable detection of occult or mutated HBV is particularly important in blood and organ donors and in patients before or with immunosuppression...